BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21338093)

  • 1. Synthesis and characterization of PEGylated toll like receptor 7 ligands.
    Chan M; Hayashi T; Mathewson RD; Yao S; Gray C; Tawatao RI; Kalenian K; Zhang Y; Hayashi Y; Lao FS; Cottam HB; Carson DA
    Bioconjug Chem; 2011 Mar; 22(3):445-54. PubMed ID: 21338093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.
    Chan M; Hayashi T; Kuy CS; Gray CS; Wu CC; Corr M; Wrasidlo W; Cottam HB; Carson DA
    Bioconjug Chem; 2009 Jun; 20(6):1194-200. PubMed ID: 19445505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
    Shinchi H; Crain B; Yao S; Chan M; Zhang SS; Ahmadiiveli A; Suda Y; Hayashi T; Cottam HB; Carson DA
    Bioconjug Chem; 2015 Aug; 26(8):1713-23. PubMed ID: 26193334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
    Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
    J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium.
    Asami T; Ishii M; Fujii H; Namkoong H; Tasaka S; Matsushita K; Ishii K; Yagi K; Fujiwara H; Funatsu Y; Hasegawa N; Betsuyaku T
    Mediators Inflamm; 2013; 2013():264260. PubMed ID: 24191131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
    Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
    J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity.
    Huang CH; Mendez N; Echeagaray OH; Weeks J; Wang J; Vallez CN; Gude N; Trogler WC; Carson DA; Hayashi T; Kummel AC
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26637-26647. PubMed ID: 31276378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.
    Hayashi T; Cottam HB; Chan M; Jin G; Tawatao RI; Crain B; Ronacher L; Messer K; Carson DA; Corr M
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R123-32. PubMed ID: 18480244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.
    Kandimalla ER; Bhagat L; Wang D; Yu D; Sullivan T; La Monica N; Agrawal S
    Nucleic Acids Res; 2013 Apr; 41(6):3947-61. PubMed ID: 23396449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and immunostimulatory activity of sugar-conjugated TLR7 ligands.
    Baba A; Wakao M; Shinchi H; Chan M; Hayashi T; Yao S; Cottam HB; Carson DA; Suda Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126840. PubMed ID: 31864800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
    Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
    Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating a Synthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles on Immunostimulatory Effects.
    Shinchi H; Komaki F; Yuki M; Ohara H; Hayakawa N; Wakao M; Cottam HB; Hayashi T; Carson DA; Moroishi T; Suda Y
    ACS Chem Biol; 2022 Apr; 17(4):957-968. PubMed ID: 35353497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
    Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
    J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand.
    Hayashi T; Yao S; Crain B; Chan M; Cottam HB; Lao F; Carson DA; Corr M
    Mediators Inflamm; 2012; 2012():262394. PubMed ID: 22619481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
    PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22.
    Wang Q; Kim SY; Matsushita H; Wang Z; Pandyarajan V; Matsuda M; Ohashi K; Tsuchiya T; Roh YS; Kiani C; Zhao Y; Chan M; Devkota S; Lu SC; Hayashi T; Carson DA; Seki E
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.
    Hu Y; Cong X; Chen L; Qi J; Wu X; Zhou M; Yoo D; Li F; Sun W; Wu J; Zhao X; Chen Z; Yu J; Du Y; Wang J
    Sci Rep; 2016 Apr; 6():23977. PubMed ID: 27046485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.